Search Results 501-510 of 5771 for 搜索引擎在线咨询邮箱：lgooxc@hotmail.com
Principal Investigator · Artificial Liver and Liver Transplantation Laboratory · Mayo Clinic 200 First St. SW Rochester, MN 55905 · Email: nyberg.scott@mayo.edu ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
In this study the investigators propose to use a daily dose of 45 mg (30 mg at 8 AM and 15 mg at 4 PM). This relatively small well-tolerated dose is likely to ...
About this study. Skeletal muscle abnormalities (sarcopenia) and frailty are common complications seen in patients with end-stage liver disease.
(Note: This email address is only for Mayo Clinic School of Graduate Medical Education and not for other Mayo Clinic College of Medicine and Science schools' ...
This study will evaluate the safety, efficacy, and pharmacokinetics of atezolizumab in combination with bevacizumab, bevacizumab + oxaliplatin, leucovorin and 5 ...
The purpose of this study is to determine if octreotide scans are more sensitive than PET scans for diagnosing carcinoid or neuroendocrine tumors. Participating ...
Single arm, open-label study to provide Defibrotide to patients diagnosed with VOD. Defibrotide is no longer available though the Emergency Use IND mechanism ( ...
About this study. This phase Ib trial studies the best way of TLR8 Agonist VTX-2337 and cyclophosphamide in treating patients with a solid tumor that has ...
Contact · Pharmacogenomics and Drug Targets Laboratory · Mayo Clinic Gonda Building, Room 19-417 200 First St. SW Rochester, MN 55905 · Phone: 507-266-6205 · Email: ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.